Ocular Therapeutix™ Reports Fourth Quarter and Year-End 2021 Financial Results and Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. SPY
3. META
4. ABBV
5. FDX
6. IBM
7. NKE
8. MU
9. PFE
10. AWK

Go back to Ocular Therapeutix™ Reports Fourth Quarter and Year-End 2021 Financial Results and Business Update

Ocular Therapeutix (OCUL) Reports In-Line Q4 EPS

February 28, 2022 4:48 PM EST

Ocular Therapeutix (NASDAQ: OCUL) reported Q4 EPS of ($0.23), in-line with the analyst estimate of ($0.23). Revenue for the quarter came in at $12.3 million versus the consensus estimate of $14.44 million.

For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.

... More